Brief: Flerie, Lipum Merger Plan Approved
March 12 (Reuters) - Flerie AB FLERIE.ST: SWEDISH COMPANIES REGISTRATION OFFICE APPROVES FLERIE AND LIPUM MERGER PLAN LIPUM TO BE DELISTED FROM NASDAQ FIRST NORTH GROWTH MARKET ON MARCH 18, 2026 Source text: ID:nMFN6Y2Js Further company coverage: FLERIE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen